Determining the Optimal Dose of AD-209 in Patients With Essential Hypertension
Clinical trial NCT04218552 · COMPLETED
Trial details
- NCT number
- NCT04218552
- Sponsor
- Addpharma Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-25
- Primary completion
- 2021-02-25
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.